On the evening of June 28th, Huada Zhizao (688114.SH) announced that it has been granted global distribution rights to nanopore sequencing products, as well as intellectual property authorization and global distribution rights to spatiotemporal omics products through cooperation with related business entities. With this, Huada Zhizao has officially gathered four major life science technology product lines, becoming the world's first high-end life science technology tool provider capable of providing high-throughput nanopore sequencing, nanopore sequencing, single-cell sequencing, and spatial omics simultaneously.
Nanopore sequencing technology is considered to be a single-molecule long-read sequencing technology with stronger overall scores. With its unique advantages such as long read lengths, fast speed, and direct detection of modifications, it can be used as an important complementary method to Huada Zhizao's core DNBSEQ sequencing technology (i.e. high-throughput nanopore sequencing technology), which helps to further expand the downstream market application scenarios for the company.
The spatiotemporal omics technology, which is known as the ultra-wide-angle billion-pixel "life camera", has high resolution and can capture large areas, enabling both "nanometer-level resolution" and "centimeter-level panoramic field of view", making it the world's leading spatial omics technology. By leveraging the influence and reputation formed by spatiotemporal omics technology in the scientific research field and combining it with Huada Zhizao's broad global marketing network and mature supply system, the maximum synergy between industry, academia and research can be achieved, allowing users to enjoy more convenient one-stop spatiotemporal omics full-process tool provision services.
The addition of these two product lines means that the company will provide global users with a richer and more complete matrix of life science technology products and solutions, and is expected to bring new growth points. According to market analysts, the current market size of spatiotemporal omics and nanopore sequencing equipment correspond to their respective leading market share and is approximately RMB 4 billion. Huada Zhizao is expected to gain 10-20% of the market share from these two business markets in the next 2-3 years, with a revenue volume of approximately RMB 400-800 million.